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The Human Secreted Group IID Phospholipase A2 (hsPLA2GIID) may be involved in the human acute
immune response. Here we have demonstrated that the hsPLA2GIID presents bactericidal and Ca2þ-
independent liposome membrane-damaging activities and we have compared these effects with the
catalytic activity of active-site mutants of the protein. All mutants showed reduced hydrolytic activity
against DOPC:DOPG liposome membranes, however bactericidal effects against Escherichia coli and
Micrococcus luteus were less affected, with the D49K mutant retaining 30% killing of the Gram-negative
bacteria at a concentration of 10 mg/mL despite the absence of catalytic activity. The H48Q mutant
maintained Ca2þ-independent membrane-damaging activity whereas the G30S and D49K mutants were
approximately 50% of the wild-type protein, demonstrating that phospholipid bilayer permeabilization
by the hsPLA2GIID is independent of catalytic activity. We suggest that this Ca2þ-independent damaging
activity may play a role in the bactericidal function of the protein.
 2012 Elsevier Masson SAS. Open access under the Elsevier OA license.1. Introduction
Secreted phospholipases A2 (sPLA2s; EC 3.1.1.4) comprise an
extensive family of water-soluble enzymes that bind to membrane
surfaces and hydrolyze the sn-2 ester bonds of membrane sn-3
glycerophospholipids [1]. The hydrolytic activity of sPLA2, which
includes Groups I, II, III, V, IX, X, XI, XII, XIII and XIV, is dependent on
the presence of a calcium ion co-factor. A mechanism for the
catalytic action of PLA2 has been proposed [2,3] in which residues
H48 and D99 activate a water molecule leading to the nucleophilic
attack at the sn-2 position of the substrate. The calcium co-factor
stabilizes the tetrahedral reaction intermediate [3], and binding is
coordinated by the carboxyl side chain of D49, the three carbonyl
oxygens of Y28, G30, G32, and two water molecules [4].
Several mammalian sPLA2s show bactericidal activity [5],
including the human Groups IIA, V, X and XII and the murine
Groups IIA, IID, IIE and V [6]. It has been suggested that some of
these sPLA2s contribute to the mammalian innate immune
response and that hydrolytic activity plays an important role in
their bactericidal activity [6,7]. The Human Secreted Group IIDica, Faculdade de Filosoﬁa,
São Paulo, Avenida Bandeir-
eto, SP, Brazil. Tel.: þ55 (0)16
lrp.usp.br (R.J. Ward).
nder the Elsevier OA license.Phospholipase A2 (hsPLA2GIID) is expressed in the spleen and
thymus [8] and possesses all the characteristics of sPLA2s in terms
of molecular size, conservation of consensus sequence and distri-
bution of disulﬁde-forming cysteine residues, the requirement for
Ca2þ and optimal pH for catalysis [8,9]. The hsPLA2GIID shares high
amino acid similarity with the human group IIA sPLA2 (hsPLA2-
GIIA), which shows potent bactericidal effect [6,10], raising the
possibility that hsPLA2GIID is also lethal to bacteria in vitro. We
have recently developed an expression system that yields heter-
ologous hsPLA2GIID [9], and here we report the bactericidal
properties of the recombinant protein. In addition, we have studied
the effects of site-directed active-site mutants on membrane per-
meabilization and bactericidal activity, and present evidence sup-
porting contributions of hydrolysis dependent and hydrolysis
independent activities to the bactericidal effect of the hsPLA2GIID.2. Materials and methods
2.1. Site-directed mutagenesis and plasmid construction
Full-length cDNA encoding the hsPLA2GIID (GenBank/EMBL
Accession NM_012400 [8]) in vector pET3a [9] was used as
a template for site-directed mutagenesis by PCR [11]. Single
mutations G30S (primer 50-GCCACCTAGTGAGCAGTGACAGCC-30,
base changes underlined), D49K (50-AGCAGCAGTCTTGGGTCTGGC-
30) and H48Q (50-AGCAGCATTTATGGGTCTGGC-30) were introduced
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desired base changes.
2.2. Recombinant protein expression, refolding and puriﬁcation
Details of the expression of heterologous hsPLA2GIID as inclu-
sion bodies in Escherichia coli BL21(DE3), together with the solu-
bilization and refolding of recombinant hsPLA2IID by dialysis and
dilution in the presence of guanidinium hydrochloride has been
previously described [9]. The refolded hsPLA2GIID and mutants
were puriﬁed by single-step cation-exchange chromatography,
dialyzed and concentrated as previously described [9]. Aliquots of
puriﬁed protein were stored at 4 C until further use.
2.3. Far ultraviolet circular dichroism (far-UV-CD)
Protein samples were prepared in 10 mM KH2PO4, pH 8.0, and
spectra were measured between wavelengths of 190e250 nmwith
a Jasco 810 spectropolarimeter (JASCO Corporation, Tokyo, Japan)
using 3 mm path length quartz cuvettes. The accumulated average
of six protein spectra was corrected by subtraction of the spectra of
the equivalent buffer in the absence of protein.
2.4. Phospholipase A2 hydrolytic activity assay
The catalytic activity of the wild-type hsPLA2GIID and mutants
was measured by the binding of the fatty acid hydrolysis product to
intestinal fatty acid binding protein conjugatedwith the ﬂuorescent
probe acrylodan (ADIFAB e Invitrogen-Molecular Probes) [12].
Unilamellar liposomes composed of a 9:1 molar ratio of dioleoyl
phosphatidylcholine (DOPC e SigmaeAldrich, St. Louis, MO, USA)
and dioleoyl phosphatidylglycerol (DOPG e SigmaeAldrich, St.
Louis, MO, USA) were prepared by reverse phase evaporation [13]
and mixed at a ﬁnal concentration of 2.16 mMwith 3 mg/mL of ADI-
FAB in 1 mL of reaction buffer (20 mM Hepes, 20 mM NaCl, 1 mM
CaCl2). Wild-type hsPLA2GIID and mutants were added to the
liposome/ADIFABmixture and the ﬂuorescence emission of ADIFAB
at 505 and 425 nm was measured with excitation at 385 nm for
a period of 30 min using an SLM 4100 spectroﬂuorimeter. The
speciﬁc activity of the enzymewas determined from analysis of the
505 nm/425 nm signal ratio as previously described [12].
2.5. Release of entrapped ﬂuorescent markers from liposomes
Unilamellar liposomes composed of DOPC:DOPG at a 9:1 molar
ratio containing 25 mM calcein (SigmaeAldrich, St. Louis, MO, USA)
were prepared by reverse phase evaporation as described previ-
ously [13], andmixedwith hsPLA2GIID to a ﬁnal protein:lipidmolar
ratio of 1:200 in 1 mL of buffer (20 mM Hepes, 150 mM NaCl, 1 mM
EGTA, pH 7.0). Membrane damagewasmonitored by the increase in
ﬂuorescence emission at 520 nm on excitation at 490 nm, and
expressed as a percentage of total calcein liberation after addition
of 5 mM Triton X-100. The effect of each mutant was measured in 5
independent experiments.
2.6. Bactericidal activity
The bactericidal effect of hsPLA2GIID and mutants was evalu-
ated against the Gram-negative bacteria E. coli (K12) and Gram-
positive bacteria Micrococcus luteus (Micrococcus lysodeikticus e
ATCC 9341) using the colony-counting method as previously
described [14]. One hundred microliters of a bacterial cell suspen-
sion at a density of 4.5105 cellsmL1 were incubated for 2 h at
37 C with wild-type hsPLA2GIID (ﬁnal concentration of 5 or 10 mg/
mL) and mutants (10 mg/mL) in incubation buffer (10 mMphosphateecitrate buffer, 1% triptone, pH 7.0), and plated on solid
LB medium. After incubation at 37 C for 12 h the number of colony
forming units (CFU) was counted, and the percentage inhibition of
colony forming units was calculated relative to the number of
colonies present in the negative control (bacterial incubation with
buffer alone). The effect of each mutant was measured in 5 inde-
pendent experiments.
3. Results and discussion
Reports of the biochemistry and biological activity of the
hsPLA2GIID are sparse, perhaps due to the difﬁculty in obtaining
recombinant protein. Using a recently developed expression
system for the enzyme [9] we have successfully expressed thewild-
type protein and the active-site mutants G30S, H48Q and D49K in
the native conformation and compared their hydrolytic and
bactericidal activities together with their calcium-independent
membrane-damaging effects against liposome membranes.
All proteins were puriﬁed to homogeneity (as evaluated by SDS-
PAGE, see supplementary ﬁgure S1). The minima at 208 and 222
and maximum at 194 nm in the far-UV-CD spectra of the wild-type
and active-site mutants (Fig. 1A) indicate a high a-helical content,
and are typical of Group II sPLA2s demonstrating that mutagenesis
caused no signiﬁcant secondary conformation change in the
hsPLA2GIID. The hydrolytic activity of the wild-type and mutant
hsPLA2GIID against DOPC/DOPG liposome membranes was
measured (Fig. 1B), and as previously reported the speciﬁc activity
of the wild-type hsPLA2GIID against the mixed DOPC/DOPG
substrate was 63 mmolmin1mg1 [9]. The H48Q mutant showed
a residual speciﬁc activity of 7.7 mmolmin1mg1, and no activity
of the D49K and G30S mutants was detected. No hydrolytic activity
was detected for the wild-type and H48Qmutant in the presence of
EGTA demonstrating that the catalytic activity is Ca2þ dependent.
Previous studies with Group I/II PLA2s has established that
active-site mutants G30S and D49K show reduced binding of the
Ca2þ co-factor and present severely impaired phospholipid
hydrolysis [15,16], and the present results conﬁrm the catalytic
activity of these mutants in the hsPLA2IID is also abolished. The
H48Q mutant presented 12% of the wild-type protein catalytic
activity, somewhat higher than the 2e4% of wild-type activity
previously observed in the H48Q mutant of hsPLA2GIIA [17]. The
crystal structures of the wild-type hsPLA2GIIA and the H48Q
mutant reveal that the positions of the active-site residues and the
Ca2þ co-factor are conserved in both proteins [17], and activation of
the catalytic water by a calcium-coordinated oxyanion has been
offered as an explanation for the catalytic activity of the H48Q
mutant [17]. A similar mechanism may underlie the reduced
activity of the H48Q mutant of the hsPLA2GIID.
The release of entrapped self-quenching ﬂuorescent dyes from
liposomes is a technique used to study the interaction of PLA2s with
membranes [18], where loss of liposome membrane integrity
results in dilution of the ﬂuorophore with a consequent increase in
the ﬂuorescence signal. Addition of hsPLA2GIID or mutants to
DOPC/DOPG liposomes resulted in loss of membrane integrity
(Fig. 2A), where the wild-type hsPLA2GIID caused 20% of total
calcein release, and the D49K and G30S mutants both caused 10%
release. The H48Q retained its membrane-damaging capacity
causing the release of 21% of the entrapped marker. These results
reveal that in the absence of Ca2þ all proteins retained membrane-
damaging activity, demonstrating that the Ca2þ-independent
membrane-damaging effect of the hsPLA2GIID does not involve
phospholipid hydrolysis.
The bactericidal effect of 5 and 10 mgmL1 hsPLA2GIID was
evaluated against the Gram-negative E. coli K12 and the Gram-
positive M. luteus (ATCC 9341). Fig. 2B shows the bactericidal
Fig. 2. (A) Ca2þ-independent membrane damage measured by calcein release frommixed DOPC:DOPG liposomes in the presence of wild-type hsPLA2IID (solid square) and mutants
G30S (open triangle), H48Q (open square) and D49K (open circle). The times at which protein (P) and Triton X-100 (T) were added are indicated. (B) Bactericidal effect of wild-type
hsPLA2GIID (WT) and mutants H48Q and D49K against Micrococcus luteus (light grey bars) and Escherichia coli (dark grey bars) as measured by reduction in the number of colony
forming units (CFU) expressed as a percentage of the control (no protein). See materials and methods for further details.
Fig. 1. (A) Far-UV-CD spectra of the wild-type recombinant hsPLA2GIID (solid line) and active-site mutants G30S (dotted line), H48Q (dotted-dashed line) and D49K (dashed line).
See materials and methods for experimental details. (B) Hydrolysis of mixed DOPC:DOPG substrate as measured by ADIFAB ﬂuorescence intensity ratio (I505/I425) changes on
addition of wild-type hsPLA2IID (solid square) and mutants G30S (open triangle), H48Q (open square) and D49K (open circle). The wild-type hsPLA2IID in the presence of 1 mM
EGTA (closed triangle) shows no activity. The wild-type hsPLA2IID and wild-type hsPLA2IIDþ EGTA activity curves are reproduced from Ref. [9] (with permission).
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positive (light grey bars) at protein concentration of 5 and 10 mg/
mL were 77% and 23% of the control values respectively, and 87%
and 47% of the control values against the Gram-negative strain
(dark grey bars). The active-site mutants H48Q and D49K both
reduced the bactericidal effect against the Gram-negative strain in
comparison with the wild-type hsPLA2GIID, causing a reduction in
CFU to 53% and 68% of the control, respectively. However, the D49K
and H48Qmutations had a lesser effect againstM. luteus, where the
number of CFU with the H48Q mutant was 87% and with the D49K
mutant 92% as compared to the control. These results demonstrate
that there is some correlation between hydrolytic and bactericidal
activities against the Gram-positive strain. However, the retained
killing effect of the D49K against the Gram-negative strain indicates
that in this case the bactericidal effects are the result of a non-
hydrolytic activity of the protein.
Interaction of catalytically inactive snake venom Group II
sPLA2s in which the Asp49 is substituted by lysine (Lys49) with
liposome membranes results in the rapid permeabilization of
liposome membranes via a Ca2þ-independent mechanism [19,20].
Recent evidence suggests that this activity is correlated with
myotoxic [21], bactericidal, and cytotoxic effects of these Lys49-
PLA2s [22,23]. The Ca2þ-independent effects of the Lys49-PLA2s
have been explained by a micelle nucleation model whereaccumulation of phospholipids at the interfacial recognition site
(IRS), the protein surface that makes contact with the membrane,
results in perturbation and permeabilization of the membrane
bilayer [24]. The cationic sPLA2s from Groups IIF, V [25] and IIA
[26] also present Ca2þ-independent membrane-damaging effects,
and we suggest that the distribution of positive residues round the
central hydrophobic patch in the IRS is a shared motif in sPLA2s
that display this non-hydrolytic activity.
Here we have presented the ﬁrst demonstration of a bacteri-
cidal effect of the hsPLA2GIID, together with evidence showing
a Ca2þ-independent membrane-damaging effect of the protein.
Active-site mutants of the hsPLA2GIID decrease the hydrolytic
activity, but do not abolished either the bactericidal effect against
E. coli (K12) or Ca2þ-independent membrane-damaging activities,
indicating that the enzyme may exert its effects through hydro-
lytic and non-hydrolytic mechanisms. This study opens the way
for future work to further understand the interplay between these
effects.
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